Celltrion
068270 · KOSPI · Biopharmaceuticals
公司简介
Celltrion is a leading South Korean biopharmaceutical company specializing in the development and manufacturing of biosimilar and innovative biologics. The company has brought multiple biosimilar products to international markets, including Remsima (infliximab biosimilar), which was among the first biosimilars approved in the US and Europe. Celltrion operates its own manufacturing facilities in Incheon, South Korea.
| 交易所 | KOSPI |
| 股票代码 | 068270 |
| 行业 | Biopharmaceuticals |
| 参考市值 美元 | $9.50B |
| 网站 | 访问官网 |
实时报价
正在加载实时价格……
| 市值 | |
| 当日区间 | |
| 52周区间 |
购买渠道
在其本地市场（KOSPI），可通过以下提供该交易所准入的全球券商进行投资：
- Interactive Brokers — Direct access to 90+ markets worldwide, including many emerging exchanges.
- Saxo Bank — Multi-market access across Asia, Europe and the Middle East.
- Charles Schwab (Global) — Foreign ordinary shares on select markets; US-listed ADRs and ETFs.
- Fidelity International Trading — International stock trading on a number of developed and emerging markets.
- Korea Exchange — 官方交易所上市信息
仅为准入信息参考，不构成推荐或购买要约。请向您的券商确认资格、费用及当前可用性。
South Korea的其他公司
SK Hynix$220.00BSamsung Electronics$200.00BSK Square$45.00BHyundai Motor$42.00BLG Energy Solution$38.00BSamsung Biologics$36.00BKia Corporation$22.00BPOSCO Holdings$18.00BKB Financial Group$17.00BShinhan Financial Group$15.50BSamsung Life Insurance$14.00BLG Electronics$12.00BHD Hyundai Heavy Industries$11.50BHana Financial Group$11.00BLG Chem$10.50BSK Telecom$10.00BWoori Financial Group$9.00BSamsung SDI$9.00BKT Corporation$8.50B
公司数据及任何实时价格均为参考性质，可能存在延迟或不准确，仅供研究参考，不构成投资建议。请以交易所、公司公告及您的券商信息为准。